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1. Introduction 
Reactive oxygen species (ROS) are low-molecular-weight inorganic and highly reactive 
compounds that are produced during normal aerobic cell metabolism. At low level, ROS 
have a transient mode of action and important physiological roles in maintaining 
intracellular cell redox status, physical-chemical properties of membranes, protein kinase 
and transcriptional factor activities. They participate in the regulation of many aspects of 
fundamental cellular function, including growth-specific and migration-related signalling 
pathways, gene expression, GTPase-dependent cytoskeletal rearrangements, cell 
proliferation and apoptosis. Multiple endogenous macromolecules, participating in cellular 
signalling networks, bear redox-active moieties (e.g., methionine, cysteine, guanine) at 
functional regions that render them sensitive to ROS. Consequently, ROS emerge, not only 
as second messengers, but also as diffusible modulators able to produce stable secondary 
signalling molecules.  
A major source of ROS are phagocytic cells such as polymorphonuclear neutrophils that are 
found activated and adherent to the endothelium or migrating through the extravascular 
tissue matrix. ROS produced by neutrophils are designed to kill the invading pathogens and 
have an important role in priming the immune system. The phagocyte NADPH oxidase, 
also referred as NOX2, is composed of several membane-bound and cytosolic subunits that 
assemble rapidly in the phagosomal or plasma membrane (Fig. 1). This allows the 
concentrated release of ROS at sites of inflammation where the pathogen is located (Ohno et 
al., 1982) and diffusion over short distances, enabling these second messengers to act on 
adjacent neighbouring targets. Since many years, it is known that ROS interactions with 
lipids contribute to disturbances in cell structure (Thaw et al., 1983) and alterations of 
functional activities (Bellomo et al., 1982; Poot et al., 1988) enhancing the ability of the 
phagocytes to kill invading microorganisms (Quinn et al., 1995).  
Under physiological conditions, ROS are eliminated by several defence mechanisms (e.g., 
antioxidant enzymes) to maintain a normal intracellular redox environment and control the 
signalling cascades.  
However, when these protective mechanisms are overwhelmed by excessive amounts of 
ROS, due to inappropriate activation of phagocytes or alterations of the antioxidant defence 
system, a situation of oxidative stress can occur resulting in abnormal physiological 
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responses. During a prolonged period, focal regions of the endothelium can be exposed to 
aberrant levels of ROS, which in turn cause the destruction of healthy tissue. Indeed, at high 
concentrations and continued exposure, ROS can damage all types of biomolecules 
including DNA, lipids, carbohydrates and proteins. 
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Fig. 1. Assembly and activation of the phagocyte NADPH oxidase, NOX2 (for reviews, see 
Babior et al., 2002; Sheppard et al., 2005). NOX2 activation is mediated by the assembly of 
cytosolic subunits (p40phox, p47phox, and p67phox) with the membrane subunits (p22phox and 
gp91phox constituting the flavocytochrome b558). Phosphorylation of p47phox, by protein 
kinases, is notably required for translocation of p47phox to the membrane and binding to 
p22phox. The guanine nucleotide exchange factor (GEF) triggers GTP binding to Rac 
promoting the membrane translocation and the binding to p67phox necessary to the assembly 
of active NOX2 and superoxide anion production. 
2. Toxicity of neutrophil NADPH oxidase (NOX2)-mediated release of ROS: 
Pathophysiological roles  
2.1 Molecular damage caused by ROS  
Irreversible oxidative modification of macromolecules including proteins, lipids, DNA and 
carbohydrates are typically viewed as the primary cellular targets of ROS and contribute to 
cell injury. Consequently, oxidized biomolecules are linked to the pathophysiology of 
multiple chronic human diseases and are the most commonly used biomarkers of oxidative 
damage isolated from tissues and biological fluids (for review, see Dalle-Donne et al., 2006). 
2.1.1 Lipid peroxidation 
Lipid peroxidation is a complex process in which oxidants, generated by NADPH oxidase of 
activated neutrophils, react the most abundantly with polyunsaturated fatty acids (e.g., 
linoleic acid and arachidonic acid) to form a variety of products including aldehydes, lipid 
radicals and hydrocarbons. Peroxidation of lipids can disrupt the organization of the 
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membrane modifying its physical properties and causing changes in fluidity and 
permeability, inhibition of metabolic processes, and alterations of ion transport (Nigam & 
Schewe, 2000).  
Polyunsaturated fatty acid residues of phospholipids nearby membrane were found to be 
extremely sensitive to oxidation by the highly reactive hydroxyl radical (Siems et al., 1995). 
The initial reaction of hydroxyl radical with polyunsaturated fatty acids produces an alkyl 
radical, which in turn reacts with molecular oxygen to form a peroxyl radical in a 
perpetuating chain reaction. Once formed, peroxyl radicals can undergo subsequent 
cyclization to generate endoperoxides, which leads to the final production of 
malondialdehyde (Mao et al., 1999; Marnett, 2002). Malondialdehyde reacts with DNA, 
predominantly with deoxyguanosine, to form exocyclic adducts most of which are 
mutagenic in mammalian cells.  
The major aldehyde product of lipid peroxidation other than malondialdehyde is 4-
hydroxy-2-nonenal (4-HNE) that is a weakly mutagenic metabolite but with a high 
cytotoxicity. The cytotoxic effects are thought to be due to the ability of 4-HNE to react 
readily with sulfhydryl groups by a Michael addition mechanism to form stable thioether 
derivatives (Esterbauer et al., 1975; Esterbauer et al., 1991). 4-HNE is a potent inhibitor of 
sulfhydryl enzymes, such as the glycolytic enzyme glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) via modification of the cysteine residue (Cys-149) at the catalytic 
site (Uchida & Stadtman, 1993). Later, it was suggested that 4-HNE inactivation of GAPDH 
is not due to the modification of the catalytic center but to the sequential and selective 
modification of amino acids (His-164, Cys-281, Cys-244, His-327 and Lys-331) primarily 
located in the surface of the GAPDH molecule (Ishii et al., 2003). 
4-HNE reacts also with selective histidine residues of proteins including insulin (which lacks 
cysteine) contributing to the cytotoxic action of 4-HNE (Uchida & Stadtman, 1992). In certain 
proteins, lysine c-amino groups, but not histidine, is the major target amino acid of 4-HNE. 
Lysine modification in glucose-6-phosphate dehydrogenase via Schiff-base formation is 
associated with a loss of enzyme activity (Sweda et al., 1993) and 4-HNE modification on 
low density lipoproteins have been implicated in the pathophysiology of atherosclerosis 
(Jessup et al., 1986; Vindis et al., 2007).  
2.1.2 Protein oxidation 
Many different types of oxidative modification of proteins can be induced by ROS. Cysteine 
and methionine residues of proteins are highly susceptible to oxidation by various forms of 
ROS. Oxidation of cysteine residues can lead to the formation of a mixed disulphide between 
protein thiol groups and low molecular weight thiol compounds (reversible S-glutathiolation). 
Carbonyl groups are major products of ROS-mediated oxidation proteins and the 
concentration of these derivatives is an adapted marker of protein oxidation (Berlett et al., 
1997; Chevion et al., 2000). Protein modifications elicited by oxidative attack on lysine, 
arginine, proline or threonine, or by secondary reaction of cysteine, histidine or lysine residues 
with carbonyl compounds can result in the formation of protein derivatives possessing highly 
reactive carbonyl groups such as aldehydes and ketones (Berlett et al., 1997). Oxidation of 
some critical methionine residues causes a complete inhibition of actin polymerization and 
destabilization of the structure of actin filaments (Dalle-Donne et al., 2002).  
Oxidative modification of proteins by ROS is implicated in the etiology and/or progression 
of a broad variety of age-related degenerative pathologies, atherosclerosis, muscular 
dystrophy, rheumatoid arthritis (Chevion et al., 2000; Moreira et al., 2010; Stadtman & 
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Berlett, 1997). Various human diseases have been associated with carbonylated proteins 
(Table 1): acute respiratory distress syndrome, Alzheimer’s disease, rheumatoid arthritis, 
chronic lung disease, and diabetes (for review, see Dalle-Donne et al., 2003). 
2.1.3 Nucleic acid oxidation 
Permanent genetic material damage due to oxidative stress can represent the first step to 
mutagenesis, carcinogenesis, and ageing. ROS are known to react with all components of 
the DNA molecule and impair DNA repair mechanisms. DNA modification can affect 
both the purine and pyrimidine bases and also the deoxyribose backbone (Aruoma et al., 
1989). DNA modification has been reported to accumulate over the life span of the cell 
participating to ageing (von Zglinicki et al., 1995). Telomere DNA is deficient in the repair 
of single-strand breaks produced by hydroxyl radicals affecting telomere length and 
hence active cell division (Oikawa et al., 2001; Petersen et al., 1998; Saretzki et al., 1999). 
The most extensively studied DNA lesion is the formation of 8-oxo-7-hydro-
deoxyguanosine (8-OH-guanine) generated by the reaction of hydroxyl radicals with 
guanine repeats. 8-OH-guanine is particularly mutagenic and cytotoxic. It is elevated in 
leukocytes and sera of patients with rheumatoid arthritis (Table 1) and probably 
participates in joint inflammation by activating immune cells, which in turn produce 
excessive pro-inflammatory cytokines (Hajizadeh et al., 2003). 
2.1.4 Carbohydrate oxidation 
Glycosaminoglycans (GAGs) are major components of extracellular matrix and their 
increased synthesis and degradation are hallmarks of chronic inflammation and tissue 
fibrosis. GAGs determine the structure, viscosity and permeability of the ground substance 
in connective tissue and play a critical role in ion transport, nutrient diffusion, water 
homeostasis, intercellular signalling and collagen synthesis. GAG oxidation is known to 
have important biological consequences in particular on endothelial cell adhesion and 
proliferation (Underwood et al., 1998; Vissers et al., 1991) that are involved in atherogenesis. 
Chondroitin sulphates and hyaluronic acid, which contain glucosamine and glucuronic acid, 
are critical GAGs present in synovial joints that have been shown to be fragmented by ROS 
(Rees et al., 2004). The hypochlorite-mediated depolymerization of GAGs has been shown to 
produce polymer-derived chloramide, the major species formed due to the reaction of 
hypochlorite with glucosamine or galactosamine residues (Hawkins & Davis, 1998; Rees et 
al., 2003). Lower molecular weight hyaluronic acid fragments accumulate during 
inflammation and may have a role in the activation of phagocytes through the stimulation of 
interleukin-1 and TNF-ǂ expression (Noble et al., 1993) resulting in an exacerbation of the 
inflammatory process and tissue damage. 
2.2 NOX2-derived ROS and inflammatory diseases 
Chronic inflammation was hypothesized as the loss of balance between apoptosis and 
wound healing leading to disruption of protective mechanisms of immune system 
(Khatami, 2005, 2008, 2009). Unresolved inflammation-induced excessive expression of pro- 
and anti-inflammatory mediators causes erosion of tissue integrity initiating the 
development of chronic inflammatory diseases or cancer (Khatami, 2011). 
Molecular alterations, induced by exaggerated ROS generation during oxidative stress, 
represent an important cause of injury in many inflammatory diseases (Table 1). ROS 
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production is a prominent feature in various cardiovascular-related diseases such as 
hypertension, atherosclerosis, and ischemic heart diseases. Moreover, it was suggested that 
ROS play a role in a variety of age-related diseases such as some neurological diseases like 
Alzheimer’s disease, type 2 diabetes or even reproductive disorders (for reviews, see 
Kukreja & Hess, 1992; Reddy et al., 2009; Valko et al., 2007). Among this pleiad of diseases, 
ROS derived from the neutrophil NADPH oxidase complex (NOX2) have notably been 
implicated in the pathophysiology of rheumatoid arthritis, atherosclerosis, chronic 
obstructive inflammatory disease and inflammation-associated cancer. 
2.2.1 Chronic inflammatory diseases 
Rheumatoid arthritis is the most common type of rheumatological disorder with a 
prevalence of 0.4% to 0.7% worldwide (Alamanos et al., 2006; Englund et al., 2010). 
Rheumatoid arthritis is a chronic, destructive, autoimmune joint disease resulting in 
enormous pathologic sequelae including pain, stiffness, deformity, swelling, as well as 
systemic effects associated with inflammation limiting activities of daily living. Rheumatoid 
arthritis principally affects peripheral synovial joints but additionally extra-articular 
complications, including atherosclerotic vascular disease and premature mortality, can be 
associated to the disease (Carroll et al., 2006). Indeed, cardiovascular complications are the 
leading cause of death (42%) among patients with rheumatoid arthritis (Callahan et al., 
1995). The pathogenesis of rheumatoid arthritis is a complex process with several 
distinguishing features involving macrophage-like synoviocytes and fibroblast-like 
synoviocytes proliferation, pannus formation, cartilage and bone erosion.  
The presence of abundant numbers of neutrophils in the synovial fluid of patients with 
rheumatoid arthritis participate to joint damage via the release of potent effectors of 
cartilage destruction such as proteases and NOX2-mediated ROS production. The 
pathogenesis of rheumatoid arthritis is predominantly linked to the formation of ROS to the 
site of inflammation and tissue lesions caused by elevated ROS concentration participate to 
the perpetuation of inflammation. These oxidative derivatives may depolymerize 
hyaluronic acid and inactivate endogenous inhibitors of proteases (Chatham et al., 1993; 
Edwards & Hallett, 1997; Larbre et al., 1994; Robinson et al., 1992). Rheumatoid arthritis 
fluids can also contain large quantities of immune complexes and their deposition has been 
considered to be a major determinant of neutrophil-mediated destructive joint process 
which is characteristic of rheumatoid arthritis. Indeed, neutrophils primed and isolated 
from the synovial fluid of patients with rheumatoid arthritis can secrete substantial 
quantities of ROS in response to immune complexes (Ottonello et al., 2002).  
Neutrophils have also been found at sites of atherosclerotic plaque rupture where they 
appear to be functionally active to generate ROS. Infiltrated neutrophils into atherosclerotic 
plaque underline the fact that these pro-inflammatory cells contribute to plaque 
vulnerability and erosion (Hosokawa et al., 2011).  
The inflammatory processes in the lung are characterized by an influx of neutrophils into 
the airways. Increased levels of NOX2-derived ROS produced by inflammatory cells of the 
airways in the lung have been recognized to contribute importantly in the pathogenesis of 
asthma and chronic obstructive pulmonary disease (Rahman, 2002). The enhanced 
expression of surface adhesion molecule Mac-1, which favours the recruitment of 
neutrophils to the inflammatory site, is coupled with an increase of NOX2 activity. It 
augments the potential of ROS to induce lung injury, contributing to the development of 
chronic obstructive pulmonary disease (Noguera et al., 2001). Oxidative stress can reduce 
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the histone deacetylase activity allowing the access of transcription factors as NF-ǋB, AP-1 
and Nrf2 to the DNA and leading to enhanced pro-inflammatory or reduced antioxidant 
gene expression in various lung cells (Ito et al., 2001; Kersul et al., 2001; Mercado et al., 
2011). Moreover, ROS may play a role in enhancing the mucus secretion through the 
modulation of enzymatic activities such as src homology 2-containing protein tyrosine 
phosphatase, p38 MAPK or receptor tyrosine kinases (epidermal growth factor receptor) 
(Jang et al., 2010; Kohri et al., 2002; Meng et al., 2002).  
2.2.2 Cancer-associated inflammation 
Persistent chronic inflammation contributes to increase the risk of cancer and promote 
cancer development and progression. The inflammatory response triggered by infection is 
involved in the pathogenesis of approximately 20% of human tumors (e.g., Helicobacter 
pylori infection is associated with gastric cancer). Cancer-related inflammation is 
characterized by the presence of infiltrating immune and inflammatory cells (notably T-
lymphocytes, tumor-associated macrophages and neutrophils) in the microenvironment of 
the tumor increasing generation of ROS and angiogenic factors, matrix-degrading enzyme 
and growth factor activities, and altering cytokine and chemokine expression. Accumulating 
evidence shows that chronic inflammation can promote an environment that is favourable to 
all the stages of human tumors. Six hallmarks have been proposed by Hanahan & Weinberg 
(Hanahan & Weinberg, 2011) to characterize the multistep of the carcinogenesis including 
sustaining proliferative signalling, evading growth suppressors, resisting cell death, 
enabling replicative immortality, inducing angiogenesis, and activating invasion and 
metastasis. It has been proposed that the genome instability leading to cancer-related 
inflammation represents the seventh hallmark of tumorigenesis (Allavena et al., 2008; 
Mantovani, 2010). 
The link between chronic inflammation and cancer has been suggested by the enhanced 
colorectal cancer susceptibility of persons with inflammatory bowel disease (e.g., 
ulcerative colitis and Crohn’s disease). Repeated injury and repair triggered by chronic 
inflammation may increase cell turnover and permanent changes in the genome leading 
ultimately to tumorigenesis. It is generally accepted that cancer initiation may be a 
pathological consequence of ROS-induced DNA lesions that in turn result in mutations 
activating oncogenes or inactivating tumor-suppressor genes (Klaunig & Kamendulis, 
2004). Chronic exposure to ROS may also alter normal cellular and molecular signalling 
pathways. ROS have been shown to activate transcription factors such NF-ǋB, AP-1 and 
STATs. NF-ǋB is known to be constitutively activated in a variety of malignancies (Brar 
et al., 2003) contributing to abnormal malignant cell division through enhanced 
expression of anti-apoptotic factors (Bcl-2), and proliferative factors, such as cyclin D1 
(Brar et al., 2003). The interest in the role of neutrophils in the inflammatory origin of 
cancer (Table 1) is recent and has considerably increased over the last years. In addition 
of its function in host defence, a critical role for NOX2-mediated ROS production has 
been pointed in the induction and development of malignant cells. Human neutrophils 
can directly damage DNA and can induce malignant transformation, which suggest that 
phagocytic cells are carcinogenic (Brar et al., 2003; Knaapen et al., 1999). The leukotriene 
LTB-4 and cytokine IL-8 are recognized to play a crucial role in neutrophil recruitment 
into airways during lung cancer in particular when progressing to the next stage of 
cancer (Carpagnano et al., 2011). 
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ROS 
NF-ǋB, p38 MAPK activation 
 Diabetes, Alzheimer’s disease 
Rheumatoid arthritis Nucleic acid oxidation 
Hyaluronic acid depolymerization 
Protease inhibitor inactivation 
 
ROS Lipid peroxidation 
Atherosclerotic plaque erosion 
Atherosclerosis 
 
ROS Histone deacetylase activity reduction 
p38 MAPK, EGFR, SHP2 modulation 
Chronic obstructive  
pulmonary disease 
 
ROS Lung cancer DNA lesions 
Transcription factor activation 
S100A8/A9 Rheumatoid arthritis 
S100A8/A9 Myeloid-derived suppressor cell 
accumulation 
p38 MAPK, p44/42 kinase activation 
Cancer 
 
ROS Carbonylated proteins 
 
 
Targets/alterations Source 
 
Table 1. Some human inflammatory diseases associated with ROS and S100A8/A9 
3. Description of the signal transduction pathways regulating NOX2 with 
emphasis on the role of Ca
2+
 mobilization 
Ca2+ is a ubiquitous second messenger that functions over a wide and defined spatio-
temporal range. Normal cytosolic free Ca2+ concentration ([Ca2+]c) in resting mammalian 
cells is maintained to low levels, in a range of 50-150 nM, compared to an endoplasmic 
reticulum and extracellular Ca2+ concentration of 500 M  and 2000 M, respectively. 
When Ca2+ channels are opened in the plasma membrane, Ca2+ can rapidly flows into the 
cytosol and reach a concentration of 1 M in a few seconds. Alternatively, Ca2+ influx can be 
delivered to low sustained Ca2+ levels to control appropriate cellular activities. A broad class 
of Ca2+ channels, differing for regulatory mechanisms and intracellular distribution, can be 
activated allowing the control by adapted Ca2+-signalling systems of many divergent 
cellular processes (exocytosis, muscle contraction, gene transcription, fertilization, meiosis, 
immune response, muscle contraction) with the right frequency and intensity. Fluctuations 
in [Ca2+]c are initiated at a localized site and diffuse inside the cell in the form of intracellular 
Ca2+ waves. In this view, neutrophils show irregular [Ca2+]c spikes during phagocytosis and 
after stimulation by the bacterial chemopeptide fMLF (Dewitt et al., 2006; Jaconi et al., 1988). 
3.1 Store-operated Ca
2+
 entry mechanism 
The receptor-mediated Ca2+ influx required for NOX2 activation in neutrophils is 
predominantly the result of the activation of the so-called store-operated Ca2+ entry (SOCE), 
which is initiated by a fall in intracellular Ca2+ store content. The store depletion is coupled 
to the opening of store-operated Ca2+ channels (SOCs) localized in the plasma membrane, 
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giving rise to a substantial Ca2+ influx. The SOCE mechanism involves G-protein-coupled 
receptors (e.g., N-formylpeptide receptor, FPR) that are associated to phospholipase C 
activation. This enzyme generates inositol 1,4,5 trisphosphate, which in turn mediates the 
depletion of Ca2+ from endoplasmic reticulum (Fig. 2). The fall of Ca2+ within the stores is 
sensed by the stromal interaction molecule protein 1 (STIM1) that translocates through the 
endoplasmic reticulum membrane to aggregate with SOCs (for review, see Putney, 2007). 
Activation of SOCs results in a Ca2+ influx into the cell and subsequent [Ca2+]c elevation.  
Direct evidence in support of SOCE has been provided by the electrophysiological 
demonstration of Ca2+ currents evoked by depleting intracellular Ca2+ stores (Hoth & 
Penner, 1992). This current was termed Ca2+ release-activated Ca2+ current (Icrac). Icrac is a 
non-voltage activated, an inwardly rectifying and a highly selective current for Ca2+ with a 
very positive reversal potential level (greater than + 60 mV) (Parekh & Penner, 1997). Icrac is 
not the only store-operated Ca2+ current, and it is now apparent that SOCE encompasses a 
family of Ca2+-permeable channels as judged by their diverse biophysical properties in 
different cell types. This disparity indicates that SOCs are likely to possess different 
molecular structures (for review, see Salido et al., 2011). Recent advances in the 
understanding of the potential molecular composition of SOCs has been the discovery of 
two families of transmembrane proteins, STIM and Orai (Peinelt et al., 2006; Prakriya et al., 
2006;  Soboloff et al., 2006). The selective Crac channel pore is formed by a tetrameric 
arrangement of Orai1 dimers, which is induced by the interaction with the C-terminus of 
STIM (Penna et al., 2009). STIM1 acts as a Ca2+ sensor/activator of Orai1 and Orai1 
constitutes the pore-forming component of Crac channels (Mercer et al., 2006). However, 
SOC currents that display distinct properties from Icrac may involve channels composed of 
transient receptor potential canonical (TRPC) subunits. In this sense, novel insights into the 
molecular components and the regulation of SOCs have been provided. TRPC1 and Orai1 
could constitute distinct Ca2+ and Icrac channels, respectively, both of which are gated by 
STIM1 in response to store depletion and contribute to SOCE (Cheng et al., 2011). 
3.2 Non-store-operated Ca
2+
 entry mechanism 
SOCE is not the only pathway for Ca2+ influx in non-excitable cells; it can be supplied by 
alternative pathways dependent on the generation of second messengers but unrelated to 
store depletion. Constitutive STIM1 in the plasma membrane could regulate the activity of 
the arachidonic-acid-regulated Ca2+-selective channels (ARC channels) (Mignen et al., 2007), 
whose activation is entirely independent of store depletion. The molecular structure of 
functional ARC channels is formed by a pentameric assembly of Orai1 and Orai3 subunits; 
these latter subunits determine the selectivity of ARC channels for arachidonic acid (Mignen 
et al., 2009). Beside ARC channels, other Ca2+ channels are activated by a variety of second 
messengers. Accumulating evidence show that members of TRPC could be activated by 
diacylglycerol (Bréchard et al., 2008; Hofmann et al., 1999). In addition, cyclic adenosine 
diphosphoribose, via its hydrolysis product (adenosine diphosphoribose), could support 
Ca2+ entry through the activation of TRPM2, a member of transient receptor potential family 
(Heiner et al., 2006; Howard et al., 1993; Lange et al., 2008).  
3.3 Ca
2+
 dependence of NOX2 activation 
It is well-known that, among complex transductional networks, Ca2+ mobilization acts a 
primordial role in receptor-mediated activation of NOX2 by neutrophils (Bréchard et al., 
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2008; Foyouzi-Youssefi et al., 1997). Knock-down of putative constituents of SOCE 
mechanism (Orai1, STIM1) by specific siRNA or decrease of SOC activity by 
pharmacological inhibitors (MRS1845, SK&F96365 or 2-APB) led to a diminished NOX2 
activity in the plasma membrane (Bréchard et al., 2008, 2009; Lee et al., 2005) underlining the 
preponderant function of SOCE in the regulation of NOX2. Activation of Ca2+ signal is 
reported as an on-switch for NOX2 activity not directly correlated with spiking activity in 
cytosolic Ca2+ (Brasen et al., 2011). 
Extracellular Ca2+ entry is also required for intraphagosomal oxidative activation and has 
been temporally correlated with NOX2 activity (Dewitt et al., 2002). Ca2+ influx appears to 
be necessary for an optimal intraphagosomal oxidative activity but not sufficient to initiate 
oxidative activation (Dewitt et al., 2002). Orai1 and STIM1 contribute to the regulation of 
phagosomal NOX2 activity through the activation of store depletion-regulated Ca2+ influx 
(Braun et al., 2009; Steinckwich et al., 2011).  
On the other hand, Itagaki et al. (Itagaki et al., 2005) suggest that Ca2+ influx occurring 
through a mechanism other than SOCE could be a relevant event to activate NOX2. In 
addition, the TRP channel, TRPC3, appears to be involved in non-SOCE-dependent 
regulation of NOX2 (Bréchard et al., 2008). 
Taken together, these results provide strong evidence for the involvement of two separate 
Ca2+ signalling pathways in NOX2 regulation but no direct correlation between non-SOCE 
or SOCE and NOX2 has been yet formally established. 
3.4 Ca
2+
 targets for the regulation of NOX2 activity 
3.4.1 Protein kinase C (PKC) 
Activation of protein kinase C (PKCs), a phospholipid-dependent family of serine-threonine 
protein kinases, is one of the earliest events in multiple signal transduction pathways that 
control a variety of cellular responses (secretion, gene expression, proliferation and muscle 
contraction) including NOX2 activity. The PKC family is categorized into three classes on 
the basis of structure and activation requirements. At least eleven different PKC isoforms 
have been characterized so far and these isoforms can be grouped into the following three 
subgroups based on Ca2+ dependency, activators and molecular structure. Conventional 
(classical) PKCs (ǂ, ǃI, ǃII, and Ǆ) are Ca2+-dependent via their C2 domains while novel (ǅ, ǆ, 
µ, ǉ and ǈ) and atypical (Ǉ and τ/ǌ) PKCs are Ca2+-independent. Both conventional and 
novel PKCs are directly activated by phosphatidylserine, diacylglycerol and phorbol esters 
(such as PMA) through their cysteine-rich C1 domains while atypical isoforms are 
insensitive to phorbol esters (Hug et al., 1993; Newton 1995; Sargeant & McPhail, 1997). 
Atypical PKCs, unlike classical and novel PKCs, feature a C1-like domain which does not 
bind to either diacylglycerol or phorbol esters. 
In addition of Ca2+-independent PKCs, conventional PKCs (ǂ and ǃ isoforms) have been 
found to regulate NOX2 activity (Fig. 2) as shown by studies using antisense strategy or 
pharmacological inhibitors. Down-regulation of PKCǃ and PKC activity affect superoxide 
anion production in neutrophil-like HL-60 cells underlying the importance of these two 
enzymes for a full activation of NOX2 (Korchak et al., 2007).  
Since it is known that NOX2 activation is critically dependent on p47phox phosphorylation, a 
lot of effort has been put into identifying PKCs responsible of this downstream event. The 
role of PKCǂ, PKCǃ, and PKCǃII in the direct phosphorylation and subsequent membrane 
translocation of p47phox has been pointed by several studies (Fontayne et al., 2002). 
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Consistent with these assumptions, Brasen et al. (Brasen et al., 2011) postulated that Ca2+-
dependent phosphorylation of NOX2 by PKCs may be in accordance with a slower 
intermediary step between [Ca2+]c elevation and increases in NOX2 activity.  
3.4.2 Monomeric G protein Rac 
Rac is a member of the Rho subfamily of small GTPases that is essential in NOX2 regulation 
(for review, see Bockoch & Diebold, 2002). Three isoforms of Rac are known but only Rac1 
and Rac2 are found in neutrophils. In the cytosol, Rac is maintained in an inactive GDP-
bound form in a complex with RhoGDI, which regulates Rac targeting to the plasma 
membrane. RhoGDI must dissociate to allow Rac to translocate to the membrane and 
interact with its downstream effectors. The guanine nucleotide exchange factors (GEF) 
induce activation by exchanging GDP for GTP, whereas GTPase activating proteins enhance 
the intrinsic rate of hydrolysis of bound GTP to GDP, resulting in Rac inactivation. Rac 
translocation is correlated with its activation (Fleming et al., 1996), but both events are 
probably regulated independently.  
Because Ras-GRF exchange factors harbor a Ca2+-calmodulin binding site (Farnsworth et al., 
1995) and Tiam1 exchange factor is phosphorylated by Ca2+-calmodulin-dependent protein 
kinase II (Fleming et al., 1999), changes in [Ca2+]c has been proposed to regulate GDP/GTP 
exchange on Rac1. PKCǂ and Ca2+/calmodulin-dependent protein kinase II phosphorylate 
the Rac1-specific exchange factor Tiam1 but only Ca2+/calmodulin-dependent protein 
kinase II regulates the activity of this exchange factor toward Rac1 (Fleming et al., 1999). 
Later, it was reported that PKCǂ, activated by thrombin, can phosphorylate RhoGDI and 
regulates the dissociation of Rac/RhoGDI complex catalyzing the release of bound GTPases, 
and subsequent Rac translocation to the plasma membrane (Mehta et al., 2001). Consistent 
with these findings, Valentin et al. (Valentin et al., 2001) determined that Ca2+ influx plays a 
primordial role in the plasma membrane translocation of Rac1 in neutrophil-like HL-60 cells 
(Fig. 2). Price et al. (Price et al., 2001) proposed a mechanism whereby [Ca2+]c elevation 
triggers conventional PKC dependent Rho-GDI phosphorylation. This event leads to Rac 
dissociation from the Rac-RhoGDI complex followed by the membrane translocation of Rac 
and its activation by guanine exchange factors.  
3.4.3 Cytosolic PLA2 (cPLA2) 
cPLA2 causes the release of arachidonic acid from membrane phospholipids via the 
hydrolysis of fatty acids at the sn-2 position (Marshall et al., 2000). Several studies put forward 
that cPLA2 is recruited at the plasma membrane in a Ca2+-dependent pathway and PKCǂ is 
required for cPLA2 activity (Li et al., 1999; Schievella et al., 1995; Shmelzer et al., 2003). 
Although underlying mechanisms need to be investigated further, cPLA2 has been associated 
with the regulation of NOX2. cPLA2 is not required for the membrane translocation of cytosolic 
NOX2 subunits but appears to have a critical role in NOX2 activation after its assembly (Dana 
el al., 1998). Indeed, arachidonic acid has been described as a cofactor enhancing the affinity of 
the assembled NOX2 for NADPH (Shmelzer et al., 2003).  
3.4.4 Ca
2+
-binding protein S100A8 and S100A9 
In recent years, members of the large S100 family of proteins containing two EF-hand Ca2+-
binding motifs have been involved in the regulation of NOX2. S100A8/A9 have been 
described as the molecular switch between the receptor-activated, Ca2+-dependent 
signalling cascade and NOX2 activation. 
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4. Intracellular functions of S100A8 and S100A9 with particular attention to 
their role in NOX2 activation 
The phagocyte-specific Ca2+-binding proteins S100A8 and S100A9 are largely expressed in 
the cytoplasm of phagocytes where they exert an intracellular function. The formation of 
S100A8/A9 heterocomplexes is probably a pre-requisite for their biological activities 
(Leukert et al., 2006). S100A8 and S100A9 are known to interact with NOX2 subunits 
(Berthier et al., 2003) and have been proposed as regulators of NOX2 activity. The relevant 
role for S100A8/A9 complex in oxidative response is probably mediated via their Ca2+-and 
phosphorylation-dependent translocation upon complex formation at the plasma membrane 
(Lominadze et al., 2005; Roth et al., 1993; Schenten et al., 2010, 2011) where NOX2 is 
activated.  
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Fig. 2. Model depicting the Ca2+-dependent regulation of NOX2 activity in neutrophils. 
Binding of the bacterial chemopeptide fMLF to its G-protein-coupled receptor (FPR) leads to 
the production of inositol 1,4,5-trisphosphate (InsP3) via phospholipase C (PLC) activation. 
InsP3 interacts with its specific receptor-channel (InsP3-R) on the surface of the endoplasmic 
reticulum (ER) triggering intracellular Ca2+ store depletion and subsequent elevation of 
[Ca2+]c. The fall of Ca2+ within the ER is sensed by the stromal interaction molecule protein 1  
(STIM1) resulting in the activation of store-operated Ca2+ channels (SOCs) at the plasma 
membrane and extracellular Ca2+ entry. Intracellular Ca2+ store depletion participates to the 
membrane translocation of S100A8/A9 and subsequent NOX2 activation. Elevation of 
[Ca2+]c induced by extracellular Ca2+ entry mediates the membrane translocation of Rac and 
stimulates PKC activity involved in the phosphorylation of cytosolic phox proteins.  
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4.1 Translocation of S100A8/A9 complex to the plasma membrane 
An elevation of [Ca2+]c is necessary for S100A8/A9 relocalization to the plasma membrane. 
Intracellular Ca2+ store depletion appears to be partly responsible for this phenomenon 
(Schenten et al., 2010) (Fig. 2) but, a supplementary signal for S100A8/A9 translocation is 
probably required. In this view, it was established that recruitment of S100A8/A9 to the 
plasma membrane is dependent on S100A9 phosphorylation and subsequently intervene in 
the regulation of NOX2 activity. This phosphorylation is mediated by p38 MAPK (Vogl et 
al., 2004) on threonine 113. It has been shown to be regulated by sphingosine kinase 
activation, which depends on the depletion of intracellular Ca2+ stores (Schenten et al., 2011). 
Furthermore, it has been hypothesized that PKCs plays a role in the regulation of 
S100A8/A9 by phosphorylating sphingosine kinases. On the other hand, PKCs could 
modulate S100A8/A9 translocation within cellular compartments by phosphorylating 
S100A8 (Guignard et al., 1996). 
4.2 Interactions between S100A8/A9 and NOX2 
To clarify NOX2 regulation processes a method, to isolate the reconstituted assembled 
NOX2 complex, has been developed, through the purification of neutrophil cytochrome b558. 
(Berthier et al., 2003; Doussière et al., 2002). The isolated NOX2 complex was able to produce 
constitutively superoxide anion in absence of any stimulus. NOX2 turnover was only 
dependent on the source of cytosol (Paclet et al., 2007). The addition of Ca2+-loaded 
S100A8/A9 to NOX2 complex prepared with neutrophil cytochrome b558 and B lymphocyte 
cytosol, increased the constitutive activity of cytochrome b558 to reach a maximum NOX2 
turnover ~120 s-1. Moreover, cytochrome b558 bound to the heparin-agarose matrix, was also 
activated by using recombinant S100A8/S100A9, instead of cytosolic factors and without 
any stimulus.  
During the activation process of NOX2, it was shown that S100A8/A9 proteins enhance or 
induce a transition from an inactive to an active state of cytochrome b558. This change of 
structural conformation was illustrated by atomic force microscopy (Berthier et al., 2003). 
The data suggest a specific interaction between S100A8/A9 and cytochrome b558. Moreover, 
S100A8/A9 complex, which enhances the affinity of p67phox for cytochrome b558, was 
introduced as a positive allosteric effector of NOX2 activity. Upon translocation, Ca2+-loaded 
S100A8/S100A9 complex appears to interact preferentially with p67phox that might favour 
the organization of a scaffold oxidase complex at the membrane level. However, 
preincubation of S100A8/S100A9 in the absence of Ca2+ led to an interaction of this complex 
with cytochrome b558 but not to its conformational change resulting in ROS production. It 
supports the fact that the role of S100A8/A9 in NOX2 activation is dependent on Ca2+ 
(Berthier et al., 2009). 
5. Pro-inflammatory roles of secreted S100A8/A9: Involvement in 
pathophysiology 
Beside their intracellular functions, S100A8 and S100A9 have been introduced as important 
pro-inflammatory factors of innate immunity secreted by phagocytes and are considered as 
damage-associated molecular pattern molecules (Foell & Roth, 2004; Loser, et al., 2010). 
S100A and S100A9 are known to have antimicrobial effects, transport arachidonic acid to 
endothelial cells and activate expression of endothelial cell adhesion molecules. 
Furthermore, the role of S100A8/S100A9 on degranulation (Simard et al., 2010) and on 
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neutrophil migration (Vandal et al., 2003) has been suggested. S100A8 was recently 
identified as an endogenous ligand of Toll-like receptor 4 (TLR4), amplifying phagocyte 
activation during inflammation upstream of TNF-ǂ-dependent effects. 
A new inflammatory syndrome characterized by an extraordinary high expression of 
S100A8/A9 proteins has been described by Sampson et al. (Sampson et al., 2002), which 
underlines the particular relevance of these two proteins for inflammatory pathologies. This 
disease is hallmarked by recurrent infections, systemic inflammation, hepatosplenomegaly, 
hyperzincaemia and hypercalprotectinaemia.  
The S100A8/S100A9 complex is found in high concentrations at local sites of inflammation 
or in the serum of patients with inflammatory diseases. Since S100A8/S100A9 are 
dramatically up-regulated in rheumatoid arthritis synovial fluid (Baillet et al., 2010; 
Berntzen et al., 1991; Frosch et al., 2000); they are considered as inflammation biomarkers 
providing more important and sensitive information about the extent of local inflammation 
in the affected joints than conventional parameters (such as C-reactive protein) of systemic 
inflammation (Foell, & Roth, 2004). S100A8/A9 may amplify pro-inflammatory cytokine 
responses through activation of NF-кB and p38 MAPK pathways in rheumatoid arthritis 
(Sunahori et al., 2006). Indeed, the receptor for advanced glycation end products (RAGE), 
able to bind S100 proteins (Hofmann et al., 1999), has been implicated in the pathogenesis of 
rheumatoid arthritis and atherosclerosis through its ability to amplify inflammatory 
pathways via the recruitment of p38 MAPK and downstream activation of NF-кB 
(Ehlermann et al., 2006). S100A8 and S100A9 proteins are likely involved in chronic 
recurrent disorders by modulating activity of matrix metalloproteinases and inducing the 
pseudotumoral transformation of the synoviocytes (Hiratsuka et al., 2006; Yong et al., 2007). 
High expression of S100A8/A9 was described in various other chronic inflammatory 
diseases, such as cystic fibrosis, inflammatory bowel disease Crohn’s disease, giant cell 
arteritis, cystic fibrosis, Sjogren’s syndrome, systemic lupus erythematosus, and progressive 
systemic sclerosis (for reviews, see Foell et Roth., 2004; Gebhardt et al., 2006). In addition, 
overexpression of these proteins has also been seen in many tumor-infiltrating cells 
(Gebhardt et al., 2006; McKiernan et al.; 2011; Su et al., 2010) underlining the fact S100A8/A9 
levels may serve as a potential marker for metastatic progression in certain type of cancers. 
Human chromosome 1q21, where S100A8 and S100A9 are clustered, is frequently 
rearranged in human epithelial tumors and tumors of soft tissues, suggesting a link between 
S100 proteins and tumor formation and metastasis (for reviews, see Gebhardt et al., 2006; 
Heizmann et al., 2007). The strong up-regulation of S100A8/A9 both in inflammation and in 
cancer suggests these proteins may play an important role in cancer-associated 
inflammation by enhancing inflammatory responses. S100A8 and S100A9 promote 
tumorigenesis by inducing the accumulation of myeloid-derived suppressor cells in the 
tumor microenvironment and thereby repress host-mediated tumor immunity (Sinha et al., 
2008). S100A8/A9 can also promote tumorigenesis by activating pro-tumorigenic signalling 
pathways. S100A8/A9 have been shown to promote cell growth via p38 MAPK and p44/42 
kinase activation in tumor cells in a RAGE-dependent manner (Ghavami et al., 2008).  
Taken together with the pro-inflammatory properties described above, the role of 
S100A8/S100A9 as protective mechanisms in inflammation should also be considered. They 
are more sensitive to oxidation than low-density lipoproteins and S100A8 is a key target of 
oxidation by peroxide, hypochlorite and nitric oxide. Thus, post-translational modifications 
of S100A8/S100A9 proteins induced by ROS may switch their biological properties from a 
pro-inflammatory towards an anti-inflammatory pattern preventing exaggerated tissue 
damage by scavenging oxidants (McCormick et al., 2005). 
www.intechopen.com
Inflammation, Chronic Diseases and Cancer –  
Cell and Molecular Biology, Immunology and Clinical Bases 
 
320 
6. Conclusion 
Despite many decades of intensive research, the etiology of most chronic inflammatory 
diseases remains elusive. Current anti-inflammatory therapy focuses on the management of 
the symptom rather on the maintenance of the function. Substantial increases in the cost of 
chronic inflammatory diseases are expected in the coming years due to the ageing of the 
population. For these reasons, there is growing interest in identifying biomarkers and 
attractive targets for novel anti-inflammatory therapies. Neutrophil NADPH oxidase and 
S100A8/A9 proteins have pro-inflammatory functions and play a fundamental role in host 
defence but also have the potential for pathological outcomes. Although physiological 
responses of neutrophils have been solidly documented, perturbations in S100A8/A9 
signalling pathways and regulation of the NADPH oxidase activity have not yet been 
adequately explored. Given their importance in the pathophysiology of various chronic 
diseases, global understanding of NADPH oxidase and S100A8/A9 roles is likely to become 
of major importance over the coming years. It bears the potential to valid novel therapies 
and diagnostic markers for disease development and risk assessment.  
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